Axcella
0 Followers
About
Axcella is designing and developing novel endogenous metabolic modulator compositions to safely reprogram metabolic dysregulation
- Website
- Headquarters
- Industry
- Social
Team
View all (20)
Bill Hinshaw
President and Chief Executive Officer
Andrew Suchoff
Senior Vice President, Chief People Officer
Laurent Chardonnet
Senior Vice President and Chief Financial Officer
Manu Chakravarthy
Executive Vice President of Clinical Development, Chief Medical Officer
Paul Fehlner J.d.
Senior Vice President, Chief Intellectual Property Officer
Stephen Mitchener
Senior Vice President, Chief Business Officer
Tony Tramontin
Senior Vice President of Research & Development, Chief Scientific Officer
Catherine A. Sohn
Director
Christopher Newgard
Scientific Advisor
Cristina M. Rondinone
Director
David R. Epstein
Director
Gary Pisano
Director
Jobs
View all (0)No jobs yet!
Wires
View all (0)No wires yet!
By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.